RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
-25.07%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$1.09B
AUM Growth
+$1.09B
(-35%)
Cap. Flow
-$108M
Cap. Flow
% of AUM
-9.93%
Top 10 Holdings %
Top 10 Hldgs %
62.57%
Holding
59
New
13
Increased
22
Reduced
11
Closed
12
Top Buys
| 1 |
Q32 Bio
QTTB
|
$26.8M |
| 2 |
Adverum Biotechnologies
ADVM
|
$19.1M |
| 3 |
SI-BONE Inc
SIBN
|
$16.8M |
| 4 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$16.6M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$15.9M |
Top Sells
| 1 |
ProQR Therapeutics
PRQR
|
$51.9M |
| 2 |
PTC Therapeutics
PTCT
|
$46.4M |
| 3 |
CORI
Corium International, Inc.
CORI
|
$34.3M |
| 4 |
Illumina
ILMN
|
$30.3M |
| 5 |
Qiagen
QGEN
|
$29.4M |
Sector Composition
| 1 | Healthcare | 91.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Pacific Biosciences
PACB
$378M
| – | – |
-2,237,607
| Closed | -$12.1M |
|
|
52
Qiagen
QGEN
$10.1B
| – | – |
-731,174
| Closed | -$29.4M |
|
53
ResMed
RMD
$39.4B
| – | – |
-147,400
| Closed | -$17M |
|
54
Viking Therapeutics
VKTX
$3.02B
| – | – |
-500,000
| Closed | -$8.71M |
|
|
BLCM
55
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| – | – |
-15,749
| Closed | -$970K |
|
|
NVTR
56
DELISTED
Nuvectra Corporation Common Stock
NVTR
| – | – |
-251,329
| Closed | -$5.52M |
|
|
CORI
57
DELISTED
Corium International, Inc.
CORI
| – | – |
-3,610,632
| Closed | -$34.3M |
|